Shanghai Xinzhi Biomed Co., Ltd.

This trial tests a one-time gene therapy called BBM-H803 for adults with severe hemophilia A. The treatment uses a harmless virus to deliver a working gene to the liver, so the body can produce its own clotting factor VIII. The study involves 55 participants and will check safety…

This early-stage study tests whether a new gene therapy called BBM-P002 is safe when injected directly into a specific brain area. It involves 18 adults who have had Parkinson's disease for at least 5 years. The main goal is to check for side effects and see how well the treatmen…